No Data
No Data
Hot stocks digest (morning session): Revolve, Gan Ltd, Kansai electrical utilities, etc.
Revoyu <8894>: 480 yen (+80 yen) hit the daily limit up. The company announced an upward revision of its performance for the fiscal year ending in October 24. Operating profit has been raised from the previous estimate of 0.37 billion yen to 0.45 billion yen, compared to a loss of 0.41 billion yen in the previous year. Due to being in the red until the third quarter, the response was straight to positive. Sales of properties and brokerage projects progressed more than expected, particularly securing and selling profit-making properties in Tokyo, leading to improved profitability. Additionally, today there is a stock consolidation.
SIGG---Buying interest at the daily limit up, significantly upward revision of the first half financial estimates.
SIGG <4386> has a buying trend with a daily limit up. The company announced an upward revision of its first-half financial estimates the previous day. Operating profit has been raised from the previous estimate of 0.19 billion yen to 0.31 billion yen, an increase of 67.2% compared to the same period last year. While high expectations for an upward revision were anticipated, it appears to be considered a larger revision than expected. Strong orders and the subsidiary acquired at the end of the previous period are also performing well. It seems that profit margin improvement and some unimplemented expense budgets have also pushed up revenue.
October 17th [Today's Investment Strategy]
[Fisco Selected Stock] [Material Stock] SIG Group <4386> 622 yen (10/16) Engaged in system development including DX support, operation of server/network equipment and software, maintenance, etc. Upwardly revised the financial estimates for the fiscal year ending March 2025. Operating profit is expected to be 30.6 million yen (67.2% increase from the previous year). This is raised by about 62% from the previous forecast. Orders are strong, and the subsidiary acquired at the end of the previous period is also performing well. Profit margin improvement has progressed, partially due to some expenses budget remaining unexecuted.
Pay attention to biochemistry and SIG Group.
On the 16th in the US stock market yesterday, the dow jones industrial average closed at 43,077.70, up 337.28 points, while the nasdaq composite index rose 51.49 points to 18,367.08. In Chicago, the Nikkei 225 futures on the Osaka Exchange saw a 260 yen increase over the daytime session to 39,450 yen. The exchange rate was 1 dollar = 149.50-60 yen. In today's Tokyo market, Hamakyore <9037> announced a share buyback with a maximum of 0.27% of the issued shares and a buying commission, with a total revenue of September increasing by 11.9% from the previous month's 7.3%, expanding the growth rate.
Heartseed, 24/10 upward revision. Operating loss of -1.059 billion yen, down from -1.965 billion yen.
Heartseed <219A> announced a revision to the financial estimates for the fiscal year ending October 2024. The revenue was revised upward from 15.3 million yen to 0.874 billion yen, and the operating loss was revised from a deficit of 1.965 billion yen to a deficit of 105.9 million yen. Under the exclusive technology partnership and licensing agreement with Novo Nordisk A/S, targeting the global market, the development milestone expected for the fiscal year ending October 2025 was achieved ahead of schedule in the fiscal year ending October 2024. Additionally, in terms of sales and general administrative expenses, in research and development costs.
SIG Group: Notice regarding revisions to consolidated earnings forecasts for the second quarter (cumulative) of the fiscal year ending March 31, 2025
No Data
No Data